Literature DB >> 21952203

Remote-conditioning ischemia provides a potential approach to mitigate contrast medium-induced reduction in kidney function: a retrospective observational cohort study.

Peter Whittaker1, Karin Przyklenk.   

Abstract

Contrast medium administration during imaging and therapeutic procedures can cause renal injury, partly due to ischemia. Therefore, we hypothesized that brief ischemia and reperfusion episodes applied at a distant site - multiple balloon inflations and deflations during angioplasty - may serve as a remote-conditioning (RC) stimulus and thereby protect against contrast-induced kidney injury. To test this hypothesis, we (1) utilized cases from a prior study in which patients undergoing emergent angioplasty for ST segment elevation myocardial infarction received either 1-3 balloon inflations (controls) or were 'conditioned' with multiple (≥4) inflations, and (2) assessed renal function for 3 days in patients with an estimated glomerular filtration rate (eGFR) of <90 ml/min/1.73 m(2) prior to revascularization (mild kidney disease). Both groups displayed increased eGFR at day 1 after angioplasty versus baseline; attributed to in-hospital hydration (control: 77 ± 14 vs. 68 ± 12 ml/min/1.73 m(2); p < 0.01; RC: 81 ± 21 vs. 69 ± 12 ml/min/1.73 m(2); p < 0.01). In controls, this improvement was transient: eGFR subsequently decreased to 70 ± 14 ml/min/1.73 m(2) at day 3 (p < 0.05). In contrast, the RC group (despite receiving 25% more contrast volume) showed no functional decline at day 3 (80 ± 14 ml/min/1.73 m(2)). These results are consistent with remote ischemic conditioning providing a novel potential approach to attenuate contrast-associated renal injury.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21952203     DOI: 10.1159/000330930

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  6 in total

1.  SYNTAX Score of Infarct-Related Artery Other Than the Number of Coronary Balloon Inflations and Deflations as an Independent Predictor of Contrast-Induced Acute Kidney Injury in Patients with ST-Segment Elevation Myocardial Infarction.

Authors:  Cheng-Wei Liu; Pen-Chih Liao; Kuo-Chin Chen; Jung-Cheng Hsu; Chung-Ming Tu; Yen-Wen Wu; Ai-Hsien Li; Shin-Rong Ke; Jiunn-Lee Lin
Journal:  Acta Cardiol Sin       Date:  2017-07       Impact factor: 2.672

2.  Renal Protection Using Remote Ischemic Peri-Conditioning During Inter-Facility Helicopter Transport of Patients With ST-Segment Elevation Myocardial Infarction: A Retrospective Study.

Authors:  Oladipupo Olafiranye; Adetola Ladejobi; Max Wayne; Christian Martin-Gill; Andrew D Althouse; Michael S Sharbaugh; Francis X Guyette; Steven E Reis; John A Kellum; Catalin Toma
Journal:  J Interv Cardiol       Date:  2016-11-04       Impact factor: 2.279

3.  Contrast-induced nephropathy following angiography and cardiac interventions.

Authors:  Roger Rear; Robert M Bell; Derek J Hausenloy
Journal:  Heart       Date:  2016-02-08       Impact factor: 5.994

4.  Effect of remote ischaemic conditioning on contrast-induced nephropathy in patients undergoing elective coronary angiography (ERICCIN): rationale and study design of a randomised single-centre, double-blind placebo-controlled trial.

Authors:  Robert M Bell; Roger Rear; John Cunningham; Anne Dawnay; Derek M Yellon
Journal:  Clin Res Cardiol       Date:  2013-11-29       Impact factor: 5.460

5.  Remote ischemic preconditioning to reduce contrast-induced nephropathy: study protocol for a randomized controlled trial.

Authors:  Thomas B Sterenborg; Theo P Menting; Yvonne de Waal; Rogier Donders; Kimberley E Wever; M Susan Lemson; Daan J A van der Vliet; Jack F Wetzels; Leo J SchultzeKool; Michiel C Warlé
Journal:  Trials       Date:  2014-04-11       Impact factor: 2.279

6.  Contrast-Induced Nephropathy and Oxygen Pretreatment in Patients With Impaired Renal Function.

Authors:  Haruki Sekiguchi; Yoichi Ajiro; Yoshie Uchida; Kentaro Jujo; Kazunori Iwade; Naohide Tanaka; Ken Shimamoto; Yukio Tsurumi; Masatoshi Kawana; Nobuhisa Hagiwara
Journal:  Kidney Int Rep       Date:  2017-08-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.